GLP-1 medicines copy a gut hormone, glucagon-like peptide-1, that signals fullness to the brain and slows how fast the stomach empties. Five molecules are sold in the United States: semaglutide, tirzepatide, liraglutide, dulaglutide and exenatide. Only three branded products carry an FDA approval for chronic weight management, and the rest are approved for type 2 diabetes. GLP-1 drugs for weight loss cost more per month than almost any other long-term prescription most people take, insurance coverage is the single biggest swing factor, and the side effects most patients meet are digestive rather than dangerous.
Why it matters: The same molecule can cost wildly different amounts depending on the brand, the pharmacy route and whether your plan excludes weight-loss drugs outright.
The Short Version
- Three weight approvals: Wegovy (semaglutide), Zepbound (tirzepatide) and Saxenda (liraglutide).
- Diabetes brands differ: Ozempic, Mounjaro, Trulicity and Rybelsus are approved for type 2 diabetes, not weight loss.
- Two payment routes: cash pay and insurance, and they almost never cost the same.
- Coverage is conditional: prior authorization, documented BMI and step therapy are normal, and flat exclusions are common.
- Side effects cluster early: nausea, vomiting, diarrhea and constipation, usually worst after a dose increase.
Which GLP-1 Drugs Exist, and What Each One Is Approved For
Brand names cause most of the confusion here. One molecule can appear under two brands at different doses, with only one of them approved for weight. Tirzepatide is technically a dual GIP and GLP-1 receptor agonist, meaning it acts on a second gut hormone receptor as well, but it is grouped with this class in practice.
| Molecule | US brand names | How it is taken | Main FDA-approved uses |
|---|---|---|---|
| Semaglutide | Ozempic, Wegovy, Rybelsus | Weekly injection; Rybelsus is a daily tablet | Type 2 diabetes (Ozempic, Rybelsus); chronic weight management and cardiovascular risk reduction in adults with established heart disease (Wegovy) |
| Tirzepatide | Mounjaro, Zepbound | Weekly injection | Type 2 diabetes (Mounjaro); chronic weight management and moderate to severe obstructive sleep apnea with obesity (Zepbound) |
| Liraglutide | Victoza, Saxenda | Daily injection | Type 2 diabetes (Victoza); chronic weight management (Saxenda) |
| Dulaglutide | Trulicity | Weekly injection | Type 2 diabetes |
| Exenatide | Byetta, Bydureon BCise | Twice daily or weekly injection | Type 2 diabetes |
Why this distinction matters for money: a pharmacist cannot swap Ozempic for Wegovy, and an insurer that covers a diabetes brand may still refuse the weight brand of the identical molecule. Liraglutide is the one molecule in the class with generic versions on the market, which changes its cash math. Our molecule-level explainers cover dosing schedules and tolerability in more detail.
What GLP-1 Drugs for Weight Loss Cost Per Month
There is no single number. Branded list prices sit near the top of the retail drug market, while manufacturer-run direct pharmacies such as NovoCare and LillyDirect, plus telehealth programs, publish lower self-pay rates for people paying without insurance. Across the semaglutide programs we track, the median advertised self-pay rate for a one-month supply is $179, with a spread of $400 between the cheapest and the most expensive.
No provider matches that filter. .
See every provider we track, with filters and sorting
Before comparing two quotes, work out what each one actually buys. These are the variables that move a monthly figure the most:
- Molecule and brand: tirzepatide and semaglutide price differently, as do their diabetes and weight brands.
- Dose tier: some programs charge more as you titrate up to a maintenance dose.
- Fee structure: a membership or visit fee billed separately from the medication is not the same as an all-in price.
- Labs and follow-ups: included in some programs, billed on top in others.
- Intro versus renewal: a first-month rate that steps up at month two changes the annual total.
- Supply length: a three-month prepay looks cheap until you divide it out.
Annual cost is the number that should drive the decision, because this is maintenance treatment and not a course of antibiotics. If you want to see how a cash rate stacks against a copay plus deductible, run both through the comparison below rather than guessing.
Insurance or cash pay, which is cheaper
Going through insurance is not automatically cheaper. Deductibles, copays and prior authorisation can make a cash-pay programme the better deal.
Coverage is never something a programme can promise: plans decide, prior authorisation is routine for GLP-1 medicines, and denials are common. Confirm with your own plan before choosing.
You can also run a direct quote against the self-pay rates we desk-check with our Cost Check Tool, which is useful when a program advertises one headline figure and bills the visit separately.
How Insurance Coverage Actually Works
Coverage for obesity medicines is narrower than coverage for the same molecules in diabetes. Many commercial plans and employer groups exclude weight-loss drugs from the formulary entirely, which is a contract decision, not a clinical one, and no appeal overturns a flat exclusion. The health policy analysts at KFF track how employer and public coverage of this class is shifting.
Where coverage does exist, expect gatekeeping. The usual sequence looks like this:
- Prior authorization: your prescriber submits documentation before the plan will pay.
- Eligibility proof: typically a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes or sleep apnea.
- Step therapy: some plans require a documented trial of an older or cheaper drug first.
- Renewal review: continued coverage can hinge on documented weight change at six or twelve months.
Two mechanics catch people out. First, the deductible phase: an approved drug can still cost full price in January if the plan pays nothing until the deductible is met. Second, coinsurance versus a flat copay. A 25 percent coinsurance on a drug with a four-figure list price is a very different bill from a fixed tier-three copay. Manufacturer savings cards also cannot be used with Medicare, Medicaid or other federal programs.
Medicare Part D has historically been barred from covering drugs used only for weight loss, though the same molecules can be covered when prescribed for an approved condition such as type 2 diabetes, cardiovascular risk reduction or obstructive sleep apnea. Medicaid coverage varies state by state. If you want programs that can bill a plan at all, filter the Telehealth Provider Directory rather than assuming, and confirm the answer with your own plan documents.
No provider matches that filter. .
See every provider we track, with filters and sorting
Compounded Versions and Why the Rules Narrowed
During the shortages, pharmacies were permitted to compound semaglutide and tirzepatide, and a large low-cost telemedicine market grew around that allowance. Once the FDA declared those shortages resolved, the legal basis for producing what regulators call essentially copies of an approved drug narrowed sharply. Some programs moved to branded supply, some to personalized formulations, and some stopped.
Compounded medicines are not FDA-approved products and are not reviewed for safety, effectiveness or manufacturing quality in the same way. The agency has warned about dosing errors with multi-dose vials and syringes, and about products sold as research-grade peptides. The FDA publishes its drug safety communications and compounding guidance on the same section of its site.
If a program still offers a compounded option, ask three things: which licensed pharmacy fills it, whether that pharmacy is a 503A or 503B facility, and whether the product contains anything other than the active molecule. Price alone is a poor filter here. Our GLP-1 Telehealth Program Comparison separates branded from compounded tracks so the figures are not read against each other.
Side Effects, Warnings, and Who Should Not Take One
Most side effects are digestive and show up in the first weeks or after a dose increase. Nausea, vomiting, diarrhea, constipation, burping and abdominal pain are the common ones. They often ease as the body adjusts, and slower titration is a standard response. Fatigue, headache and injection-site reactions also appear on the labels.
Signs that need prompt medical attention
- Severe, persistent abdominal pain, with or without vomiting, which can signal pancreatitis.
- Right upper abdominal pain, fever or yellowing skin, which can signal gallbladder disease.
- Vision changes in people with diabetic retinopathy.
- A neck lump, hoarseness or trouble swallowing.
- Signs of dehydration or low blood sugar when combined with insulin or a sulfonylurea.
The weekly products in this class carry a boxed warning based on thyroid C-cell tumors seen in rodents. They are not for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and they are not recommended during pregnancy. Plain-language summaries for each molecule are kept on MedlinePlus, the National Library of Medicine’s consumer drug reference. Anyone with a history of pancreatitis, gastroparesis, severe gastrointestinal disease or an eating disorder should raise it before starting, not after.
Deeper molecule-specific detail sits in our Semaglutide Side Effects Breakdown and in How Tirzepatide Is Dosed, including what dose escalation normally looks like.
Who Qualifies, and What a Telemedicine Visit Covers
Eligibility for weight management generally starts with BMI: 30 or higher, or 27 or higher alongside a weight-related condition. BMI is a crude screen rather than a diagnosis, and clinicians weigh waist measurement, blood pressure, lipids and A1c alongside it.
BMI calculator
Most weight-loss programmes screen on BMI before they will prescribe. This is the number they will use.
A screening number, not a diagnosis. It does not distinguish muscle from fat, and it reads high for muscular builds.
A credible intake asks about medical history, current medicines, prior weight-loss attempts, mental health history and family history of thyroid cancer. Many programs order or require baseline labs, commonly A1c, a metabolic panel, lipids and sometimes thyroid function. Lab work may be billed by the lab, not the program, so ask who sends that invoice.
A video or asynchronous visit is a reasonable route for a straightforward case. In-person care is the better call when you have unexplained weight loss, complex diabetes on insulin, significant kidney or liver disease, an active gastrointestinal condition, or you are pregnant or trying to conceive. State licensing also matters: a clinician must hold a license in the state where you are physically located at the time of the visit.
How to Compare Programs Without Paying Twice for the Same Thing
Work through the same questions for every program you are weighing:
- What does the monthly figure include: medication, visits, titration changes, messaging?
- Is the medication branded or compounded, and which pharmacy fills it?
- Does the rate renew at the same price after the first month or the first dose step?
- Who pays for labs, and are repeat labs required?
- Can they bill your insurer, and will they handle prior authorization paperwork?
- What happens if you stop: refund terms, cancellation notice, unused supply?
- Who is the prescriber, and are they licensed in your state?
Best on value
What you get for what you pay.
- Found8.9 / 10
- ShedRx8.2 / 10
- Henry Meds8.2 / 10
- Lumimeds8 / 10
- Amble8 / 10
Lowest monthly price
Cheapest verified plan for a new self-pay patient.
- Amazon One Medical$17/mo
- LifeMD$19/mo
- PlushCare$20/mo
- Hims$22/mo
- Strut Health$25/mo
Ranked from our own scores, recomputed as data changes. Providers cannot pay for a place.
RatedByPatients is an independent comparison and review site, not a clinic or a pharmacy. Provider pricing here is desk-checked against live provider sites and re-checked monthly, editorial scores follow our published Scoring Methodology, and member reviews are moderated. Sponsored placement is always labeled and never changes a score or a rank.
What to Do Next
Start with your plan, not with a program. Call the member services number on your insurance card and ask two specific questions: is this drug class excluded from the formulary, and if not, what does prior authorization require. That single call decides whether you are shopping a copay or a cash rate.
If you land on cash pay, price the full year rather than the first month, and compare the same supply length across programs. Our Medication Index covers each molecule in depth, and the Free Health Calculators can turn a monthly figure into an annual one before you commit.
Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.


